← Feed
0
Congress trades, 6 months
After each filing
No purchase or sale on this ticker by a member of Congress or an insider yet.
Filings for HLVX
15 held · newest 5 15 held · newest 2 See all 15 filings for HLVX
Aeon news and offers by email
New sources, new features and offers like our founding price. A few times a month at most. Stop any time.
Signal history
No signal for this ticker yet. A signal is written when insider buying here scores one dot or more.
Stakes 4
Sep 30, 2025
Schedule 13G, amended
EcoR1 Capital, LLC: 0%, 0 shares
Sep 17, 2025
Schedule 13D, amended
TANG CAPITAL MANAGEMENT, LLC: 0%, 0 shares
Sep 17, 2025
Schedule 13D, amended
Takeda Pharmaceutical Company Limited: 0%, 0 shares
Sep 17, 2025
Schedule 13D, amended
Frazier Life Sciences Public Fund, L.P.: 0%, 0 shares
Schedule 13D is filed within 5 business days of crossing 5 percent by an investor who may seek to influence the company. Schedule 13G is filed by a passive holder, and a large institution has up to 45 days after the quarter end.
Government contracts, last 12 months Awards of $10M and up, from USAspending · context, not a signal
No contracts of $10M or more in the last 12 months.
Lobbying Last four quarters
No lobbying reports on file.